November 24, 2020
Business News

Pfizer says it will not have a coronavirus vaccine until late November, allaying fears of a rush for approval before Election Day – The Washington Post

Chief executive Albert Bourla wrote in the letter that while the company projects it may have enough data to determine whether the vaccine is effective in October, there will not be sufficient safety follow-up to satisfy criteria laid out by the Food and Drug Administration until late November.
A key point that Id like to make clear is that effectiveness would satisfy only one of the three requirements and, alone, would not be enough for us to apply for approval for public use, Bourla said. Saf…

Click here to view the original article.

Related Posts

You might also like ...

Riassunto: Il responsabile delle strategie Casey Potenzone lascia Nexway
Hastings Direct and Cambridge Mobile Telematics Partner to Offer Customers Better Pricing on Their Premiums
Eastman CFO Willie McLain to Address the Citi Basic Materials Virtual Conference